Piper Sandler Maintains Overweight on MDxHealth, Lowers Price Target to $6-Report released on 8th Nov 2023

Benzinga · 11/09/2023 20:06
Piper Sandler analyst Jason Bednar maintains MDxHealth (NASDAQ:MDXH) with a Overweight and lowers the price target from $10 to $6.